勃林格殷格翰的思力华多少钱一盒？

It is a classic drug for the stable treatment of chronic obstructive pulmonary disease (COPD). The effect lasts for 24 hours, so it only needs to be used once a day. In order to ensure the therapeutic effect, it is best for patients to use Slivar at the same time every day, spray twice each time, and do not overdose. Slivar is a prescription drug and you must consult your doctor before starting treatment. It should not be used if the patient is allergic to the drug or its ingredients.

Seriva is a long-acting anticholinergic drug developed by Boehringer Ingelheim. Boehringer Ingelheim was founded by Albert Boehringer in 1885. It entered China in 1994. The Chinese headquarters is located in Shanghai. It is the first multinational company to set up a biopharmaceutical production base and set up biopharmaceutical contract production in China. It is also the first biopharmaceutical company to pilot the marketing authorization holder system, and completed the production, development and marketing of entrusted products during the pilot period.

Slivar has similar affinity for five choline receptors (M1-M5). It dilates bronchial smooth muscle by binding to M3 receptors on smooth muscle. This effect is competitive and reversible. In vivo and in vitro studies have shown that Slihua has a dose-dependent and sustainable 24-hour inhibition of methacholine-induced bronchoconstriction. Sliva has outstanding localization selectivity in its dilation effect on bronchial tubes.

In clinical trials, patients' lung function (FEV1) was statistically significantly improved after taking Slivar, and it had a similar safety profile to tiotropium or olodaterol. We already have a certain understanding of Boehringer Ingelheim’s Spliva, but how much does a box of it cost?

It is understood that the current price is relatively low at about 170$ per box, which is affordable for most domestic patients. If you have purchase needs, please further consult the medical companion travel service for specific information.

Recommended related hot articles: /newsDetail/88968.html